Healthcare and Science Division of Thomson Reuters, Washington, DC, USA.
Health Aff (Millwood). 2011 Feb;30(2):284-92. doi: 10.1377/hlthaff.2010.0765.
The United States invests a sizable amount of money on treatments for mental health and substance abuse: $135 billion in 2005, or 1.07 percent of the gross domestic product. We provide treatment spending estimates from the period 1986-2005 to build understanding of past trends and consider future possibilities. We find that the growth rate in spending on mental health medications-a major driver of mental health expenditures in prior years-declined dramatically. As a result, mental health and substance abuse spending grew at a slightly slower rate than gross domestic product in 2004 and 2005, and it continued to shrink as a share of all health spending. Of note, we also find that Medicaid's share of total spending on mental health grew from 17 percent in 1986 to 27 percent in 2002 to 28 percent in 2005. The recent recession, the full implementation of federal parity law, and such health reform-related actions as the planned expansion of Medicaid all have the potential to improve access to mental health and substance abuse treatment and to alter spending patterns further. Our spending estimates provide an important context for evaluating the effect of those policies.
2005 年为 1350 亿美元,占国内生产总值的 1.07%。我们提供了 1986 年至 2005 年期间的治疗支出估计数,以了解过去的趋势并考虑未来的可能性。我们发现,精神健康药物支出的增长率——近年来精神健康支出的主要驱动因素——大幅下降。因此,2004 年和 2005 年精神健康和药物滥用支出的增长速度略低于国内生产总值,并且其在所有卫生支出中的份额继续缩小。值得注意的是,我们还发现,1986 年医疗补助计划占精神健康总支出的 17%,到 2002 年增长到 27%,到 2005 年增长到 28%。最近的经济衰退、联邦平价法的全面实施以及与医疗改革相关的行动,如计划扩大医疗补助计划,都有可能改善精神健康和药物滥用治疗的可及性,并进一步改变支出模式。我们的支出估计为评估这些政策的效果提供了重要背景。